https://www.selleckchem.com/pr....oducts/rocilinostat-
egies, staff protection, changes adopted in the fellowship program, and the effectiveness of such measures. Recent breakthrough results from immune checkpoint inhibitors (ICIs) have paved the way to a new era of cancer immunotherapy, and have thus led to a paradigm shift of cancer treatment. In particular, inhibition of the antiprogrammed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) axis with ICI, including nivolumab and pembrolizumab, has been emerging as a novel treatment strategy for advanced gastric cancers. An acc
Like
Comment
Share
